Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
67.30    -0.70 (-1.03%)
Bid:
67.20
Ask:
67.40
Spread: 0.20 (0.298%)
Market Cap: £594.55m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

SAYE scheme

8 Oct 2019 18:08

RNS Number : 2049P
IP Group PLC
08 October 2019
 

FOR RELEASE ON

08 October 2019

 

IP Group plc - SAYE scheme

 

IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property-based businesses, announces the following grant of options over the Company's Ordinary Shares of 2p each ("Shares"), under its Save As You Earn ("SAYE") Sharesave Plan, to the following Directors and a PDMR of the Company.

 

 Name

Plan duration

Number of options granted

Directors/PDMR

Greg Smith

3 years

34,816

Michael Townend

3 years

34,816

David Baynes

3 years

34,816

Sam Williams

3 years

34,816

 

In addition to the above, options over a total of 995,401 Shares were granted to certain other employees of the Group under the Sharesave Plan.

All of the above SAYE options have been granted on 8 October 2019 at an exercise price of 51.7p per share, with the SAYE contracts commencing on 1 November 2019. The exercise price was set in accordance with HM Revenue & Customs rules for Sharesave plans.

Permitted exercise periods are for a period of six months from the end of the plan period, ordinarily 1 November 2022 for the 3-year plan and 1 November 2024 for the 5-year plan.

The Company currently has 1,059,144,595 Ordinary Shares in issue. 

The following information is being disclosed pursuant to the requirements of MAR.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

 Name

Michael Townend

2

Reason for the notification

a)

 Position/status

Director CIO

b)

 Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 Name

IP Group plc

b)

 Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

 Nature of the transaction

Grant of Options under the IP Group plc SAYE

c)

 Currency

GBP

d)

 Price(s) and volume(s)

Name(s)

Price(s)

Volume(s)

Michael Townend

51.7p

34,816

e)

 Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

Aggregated number of Options granted under the SAYE to Director / PDMR on 8 October 2019: 34,816Price: 51.7p

f)

Date of the transaction

08 October 2019.

g)

 Place of the transaction

London Stock Exchange, Main Market

 

2

Details of the person discharging managerial responsibilities/person closely associated

a)

 Name

Greg Smith

2

Reason for the notification

a)

 Position/status

Director Chief Financial Officer

b)

 Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 Name

IP Group plc

b)

 Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

 Nature of the transaction

Grant of Options under the IP Group plc SAYE

c)

 Currency

GBP

d)

 Price(s) and volume(s)

Name(s)

Price(s)

Volume(s)

Greg Smith

51.7p

34,816

e)

 Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

Aggregated number of options granted under the SAYE to Director / PDMR on 8 October 2019: 34,816Price: 51.7p

f)

Date of the transaction

08 October 2019.

g)

 Place of the transaction

London Stock Exchange, Main Market

1

Details of the person discharging managerial responsibilities/person closely associated

a)

 Name

David Baynes

2

Reason for the notification

a)

 Position/status

Director Chief Operating Officer

b)

 Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 Name

IP Group plc

b)

 Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

 Nature of the transaction

Grant of Options under the IP Group plc SAYE

c)

 Currency

GBP

d)

 Price(s) and volume(s)

Name(s)

Price(s)

Volume(s)

David Baynes

51.7p

34,816

e)

 Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

Aggregated number of Options granted under the SAYE to Director / PDMR on 8 October 2019: 34,816Price: 51.7p

f)

Date of the transaction

08 October 2019.

g)

 Place of the transaction

London Stock Exchange, Main Market

1

Details of the person discharging managerial responsibilities/person closely associated

a)

 Name

Sam Williams

2

Reason for the notification

a)

 Position/status

PDMR Managing Partner, Life Sciences

b)

 Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 Name

IP Group plc

b)

 Legal Entity Identifier

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

ISIN: GB00B128J450

b)

 Nature of the transaction

Grant of Options under the IP Group plc SAYE

c)

 Currency

GBP

d)

 Price(s) and volume(s)

Name(s)

Price(s)

Volume(s)

Sam Williams

51.7p

34,816

e)

 Aggregated information

- Aggregated volume

- Price

- Aggregated total

 

Aggregated number of Options granted under the SAYE to Director / PDMR on 8 October 2019: 34,816Price: 51.7p

f)

Date of the transaction

08 October 2019.

g)

 Place of the transaction

London Stock Exchange, Main Market

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Angela Leach, Company SecretaryLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiary IP Capital), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in approximately 100 early-stage to mature businesses across four main sectors -- Biotech, Cleantech, Healthcare and Technology. The Company is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFSMFWAFUSESS
Date   Source Headline
3rd Jun 20267:00 amRNSHolding(s) in Company
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
29th May 20267:00 amRNSHolding(s) in Company
28th May 20267:00 amRNSHolding(s) in Company
13th May 20265:30 pmRNSNotice of AGM
12th May 20269:10 amRNS-REnterprise reports positive results from P2 trial
11th May 20264:25 pmRNSHolding(s) in Company
11th May 20264:19 pmRNSHolding(s) in Company
7th May 20267:00 amRNSAppointment of Chair Designate
23rd Apr 202612:18 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNS-RFirst Light announces £25m successful first close
15th Apr 20265:00 pmRNSAnnual Financial Report
14th Apr 20269:25 amRNSHolding(s) in Company
30th Mar 20262:00 pmRNSNew climate fund launch with Australia's CEFC
26th Mar 202610:00 amRNSHolding(s) in Company
25th Mar 20262:00 pmRNSHolding(s) in Company
19th Mar 20265:30 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
17th Mar 20267:00 amRNSIP Group plc 2025 Annual Results Release
13th Mar 20265:45 pmRNSHolding(s) in Company
12th Mar 202611:00 amRNSHolding(s) in Company
12th Mar 20269:00 amRNSNotice of Results
12th Mar 20269:00 amRNSNotice of Results
4th Mar 20267:00 amRNS-RPortfolio company Oxa raises $103m in Series D
26th Feb 20262:53 pmRNSHolding(s) in Company
26th Feb 20269:30 amRNSHolding(s) in Company
25th Feb 20265:51 pmRNSHolding(s) in Company
11th Feb 20269:01 amRNS-RMicrobiotica announces positive P1b trial results
30th Jan 20267:00 amRNSHolding(s) in Company
29th Jan 20267:00 amRNSHolding(s) in Company
20th Jan 202612:36 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSDirectorate change
14th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20266:25 pmRNSHolding(s) in Company
7th Jan 20262:06 pmRNSPulmocide announces termination of Phase 3 study
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
18th Dec 20254:13 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20255:26 pmRNSHolding(s) in Company
4th Dec 20254:13 pmRNSHolding(s) in Company
1st Dec 20255:37 pmRNSTotal Voting Rights
20th Nov 20257:00 amRNSCompletion of share buyback programme
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20251:10 pmRNSArtios completes oversubscribed $115m financing
14th Nov 20255:47 pmRNSTransaction in Own Shares
14th Nov 20258:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.